Nevertheless, a number of key tumour suppressor genes are frequently affected, including those encoding cyclin-dependent kinase inhibitor 2A (CDKN2A), BRCA1-associated protein 1 (BAP1) and neurofibromin 2 (NF2) [17–19] [Fig. 2]. This evidence concerns the gene BAP1 and neoplasm.